- Home
- / PolyPeptide Group
- / Operating Metrics
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
PolyPeptide Group key operating metrics including Phase III Trials Products, environmental, and social and governance score (ESG).
Phase III Trials Products
31
3.3%
H1, 2023
Projects
226
3.7%
H1, 2023
Phase II Trials Products
37
2.6%
FY, 2022
Operating Metrics
Environmental, Social and Governance (ESG)
Overall
50-59 out of 100
Community
Employees
Environment
Governance
Premium Content only available in Craft’s Intelligence Portal
Learn moreSource:CSRHub